--- title: "688351.SH (688351.SH) — Related News" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/688351.SH/news.md" symbol: "688351.SH" name: "688351.SH" parent: "https://longbridge.com/en/quote/688351.SH.md" datetime: "2026-03-13T13:30:23.019Z" locales: - [en](https://longbridge.com/en/quote/688351.SH/news.md) - [zh-CN](https://longbridge.com/zh-CN/quote/688351.SH/news.md) - [zh-HK](https://longbridge.com/zh-HK/quote/688351.SH/news.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/688351.SH/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/688351.SH/news.md) # 688351.SH (688351.SH) — Related News ### [Endovastec: The detachable fiber embolization spring has obtained the medical device registration certificate](https://longbridge.com/en/news/279020341.md) *2026-03-13T09:50:04.000Z* > Endovastec announced that its holding subsidiary, Shanghai Hongmai Medical Technology Co., Ltd., has obtained the medica ### [China's MicroPort Soars After US Grants Its New Stent Breakthrough Device Status](https://longbridge.com/en/news/277429546.md) *2026-03-02T08:31:17.000Z* > Shares of MicroPort Endovascular MedTech Group surged 10.2% to CNY111.80 after the US FDA granted Breakthrough Device De ### [Zhitong A-share lock-up release overview | March 2](https://longbridge.com/en/news/277382563.md) *2026-03-02T01:01:06.000Z* > On March 2nd, a total of 14 listed companies had their restricted shares unlocked, with a total market value of approxim ### [MICROPORT's subsidiary Endovastec reported a net profit of 560 million RMB last year, an increase of 12%, with revenue also rising by 12%](https://longbridge.com/en/news/277380962.md) *2026-03-02T00:40:00.000Z* > MicroPort announced that its subsidiary Endovastec (Shanghai Stock Exchange: 688016) reported an annual performance for ### [Overview of A-share lock-up stock release: Lock-up stocks worth 17.843 billion yuan are released today](https://longbridge.com/en/news/277375693.md) *2026-03-01T23:41:25.000Z* > On Monday, 10 companies had their restricted shares unlocked, with a total unlock volume of 952 million shares, valued a ### [Next week, shares worth 36.277 billion yuan will be unlocked, with MICROPORT EP leading at 8.094 billion yuan](https://longbridge.com/en/news/277203222.md) *2026-02-27T13:18:25.000Z* > Next week, 30 companies will have their restricted shares unlocked, totaling 1.406 billion shares with a total market va ### [MicroPort: Endovastec's net profit attributable to the parent company in 2025 is approximately 563 million yuan, a year-on-year increase of 12.17%](https://longbridge.com/en/news/277193894.md) *2026-02-27T12:01:13.000Z* > MicroPort announced the performance preliminary report of Endovastec for 2025, with total operating revenue of approxima ### [AI is expected to empower surgical robots to achieve autonomous operation, and institutions are optimistic about the valuation increase of industry chain companies (including concept stocks)](https://longbridge.com/en/news/275679627.md) *2026-02-12T00:47:17.000Z* > According to research by Frost & Sullivan, the market size of surgical robots in China is expected to grow from 7.2 bill